ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer

American Journal of Human Genetics

Volumn 62, Issue 2, 1998, Pages 334-345

  Stankovic, T ^a   Kidd, A M J ^b   Sutcliffe, A ^a   McGuire, G M ^a   Robinson, P ^a   Weber, P ^a   Bedenham, T ^a   Bradwell, A R ^a   Easton, D F ^c   Lennox, G G ^d   Haites, N ^b   Byrd, P J ^a   Taylor, A M R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NEUROLOGIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 17344362697     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301706     Document Type: Article

References (28)

1. Ad Hoc Committee on Mutation Nomenclature (1996) Update on nomenclature for human gene mutations. Hum Mutat 8:197-202
2. Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 1499
3. Athma P, Rappaport R, Swift M (1996) Molecular genotyping shows that ataxia telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 42:130-134
4. Byrd PJ, McConville CM, Cooper P, Parkhill J, Stankovic T, McGuire GM, Thick JA, et al (1996) Mutations revealed by sequencing the 5′ half of the gene for ataxia telangiectasia. Hum Mol Genet 5:145-149
5. Easton DF (1994) Cancer risk in A-T heterozygotes. Int J Radiat Biol Suppl 66:S177-S182
6. FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, et al (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15:307-310
7. Gardella R, Belletti L, Zoppi N, Marini D, Barlati S, Colombi M (1996) Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the localisata variant of recessive dystrophic epidermolysis bullosa. Am J Hum Genet 59:292-300
8. Gilad S, Khorsavi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, et al (1996) Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet 5:433-439
9. Keegan KS, Holtzman DA, Plug AW, Christenson ER, Brainerd EE, Flaggs, G, Bentley NJ, et al (1996) The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes Dev 10:2423-2437
10. Krawczak M, Cooper DN (1997) The human gene mutation database. Trends Genet 13:121-122
11. Lakin ND, Weber P, Stankovic T, Rottinghaus ST, Taylor AMR, Jackson SP (1996) Analysis of the ATM protein in wild type and ataxia telangiectasia cells. Oncogene 13: 2707-2716
12. Liu Q, Sommer SS (1995) Restriction endonuclease finger-printing (REF): a sensitive method for screening mutations in long, contiguous segments of DNA. BioTechniques 18: 470-477
13. McConville CM, Stankovic T, Byrd PJ, McGuire GM, Yao Q-Y, Lennox GG, Taylor AMR (1996) Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet 59:320-330
14. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, et al (1995a) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753
15. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Shiloh Y, Rotman G (1995b) The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4:2025-2032
16. Sedgwick RP, Boder E (1991). Ataxia-telangiectasia. In: de Jong JMJV (ed) Hereditary neuropathies and spinocerebellar atrophies. Vol 16 in: Handbook of clinical neurology. Elsevier, Amsterdam, pp 347-423
17. Spector BD, Filipovich AM, Perry GS, Kersey KS (1982) Epidemiology of cancer in ataxia-telangiectasia. In: Bridges BA, Harnden DG (eds) Ataxia-telangiectasia - a cellular and molecular link between cancer, neuropathology and immune deficiency. John Wiley, Chichester, pp 103-138
18. Swift M, Morell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT (1986) The incidence and gene frequency of ataxia telangiectasia in the United States. Am J Hum Genet 39:573-583
19. Swift M, Morrell D, Massey RB Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831-1836
20. Taylor AMR, Flude E, Laher B, Stacey M, McKay E, Watt J, Green SH, et al (1986) Variant forms of ataxia telangiectasia. J Med Genet 24:669-677
21. Taylor AMR, Hernandez D, McConville CM, Woods CG, Stacey M, Biggs P, Byrd PJ, et al (1996a) Malignant disease and variations in radiosensitivity in ataxia telangiectasia patients. In: Eeles RA, Ponder BAJ, Eastern DF, Horwich D (eds) Genetic predisposition to cancer. Chapman & Hall, London, pp 138-151
22. Taylor AMR, Metcalfe JA, Thick J, Mak YF (1996b) Leukaemia and lymphoma in ataxia telangiectasia. Blood 87: 423-438
23. Telatar M, Wang Z, Udar N, Liang T, Bernatowska-Matuszkiewicz E, Lavin M, Shiloh Y, et al (1996) Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening. Am J Hum Genet 59:40-44
24. Uziel T, Savitsky K, Platzer M, Ziv Y, Helbitz T, Nehls M, Boehm T, et al (1996) Genomic organisation of the ATM gene. Genomics 33:313-320
25. Vorechovsky I, Luo L, Dyer MJS, Catovsky D, Amlot PL, Yaxley JC, Foroni L, et al (1997) Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T cell leukaemia. Nat Genet 17:96-99
26. Wright J, Teraoka S, Onengut S, Tolun A, Gatti RA, Ochs HD, Concannon P (1996) A high frequency of distinct ATM mutations in ataxia-telangiectasia. Am J Hum Genet 59: 839-846
27. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D (1996) Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects and thymic lymphoma. Genes Dev 10: 2411-2422
28. Ying KL, DeCoteau WE (1981) Cytogenetic anomalies in a patient with ataxia, immune deficiency and high alpha-fetoprotein in the absence of telangiectasia. Cancer Genet Cytogenet 4:311-317